Arrowhead Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ARWR Nasdaq 8731 https://arrowheadpharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arrowhead Pharmaceuticals Inc

Turnstone Biologics Appoints William Waddill to its Board of Directors - Apr 16th, 2024 1:00 pm
Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 6.6% drop adds to a year losses - Apr 16th, 2024 12:57 pm
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo - Apr 7th, 2024 1:00 pm
Insider Sell: Chief Discovery/Trans Medicine James Hamilton Sells 6,000 Shares of Arrowhead ... - Apr 4th, 2024 5:27 am
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Apr 1st, 2024 8:30 pm
Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data - Mar 25th, 2024 12:00 pm
The 3 Most Undervalued Russell 2000 Stocks to Buy in March 2024 - Mar 11th, 2024 10:53 pm
Arrowhead Pharmaceuticals Inc CFO Kenneth Myszkowski Sells 40,000 Shares - Mar 9th, 2024 4:29 am
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy - Mar 8th, 2024 12:30 pm
Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expensive For A Reason? A Look At Its Intrinsic Value - Mar 6th, 2024 12:22 pm
Arrowhead Pharmaceuticals to Participate in Upcoming March 2024 Conferences - Mar 4th, 2024 12:30 pm
Arrowhead Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations - Feb 8th, 2024 11:33 am
ARWR: Pipeline Reprioritization to Reduce Cash Burn by up to $100 Million This Fiscal Year - Feb 8th, 2024 11:00 am
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2024 Earnings Call Transcript - Feb 7th, 2024 3:42 pm
Q1 2024 Arrowhead Pharmaceuticals Inc Earnings Call - Feb 7th, 2024 3:02 pm
Arrowhead Pharmaceuticals Inc Reports Fiscal Q1 2024 Results with Strategic Focus on ... - Feb 6th, 2024 9:32 pm
Arrowhead Pharmaceuticals to Webcast Fiscal 2024 First Quarter Results - Jan 22nd, 2024 9:01 pm
Swelling losses haven't held back gains for Arrowhead Pharmaceuticals (NASDAQ:ARWR) shareholders since they're up 156% over 5 years - Jan 22nd, 2024 1:01 pm
Bank of America Says These 3 Healthcare Stocks Have up to ~160% Upside Potential - Jan 18th, 2024 10:37 am
Arrowhead Pharmaceuticals Inc CFO Kenneth Myszkowski Sells 16,104 Shares - Jan 9th, 2024 8:02 am